DYN
Dyne Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +5.9% ·
flujo de acciones +28.2% ·
nuevas posiciones netas 0.0%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +1 | 73.73M | $1.63B | +7 | −5 |
| Q1 2026 | 87 | -4 | 78.51M | $1.42B | +7 | −12 |
| Q4 2025 | 92 | 0 | 87.58M | $1.71B | +2 | −1 |
| Q3 2025 | 18 | +1 | 57.06M | $721.88M | +1 | −1 |
| Q2 2025 | 15 | +2 | 34.50M | $328.45M | +2 | — |
| Q1 2025 | 10 | -1 | 12.46M | $130.33M | +1 | −2 |
| Q4 2024 | 11 | 0 | 14.93M | $351.71M | +1 | −1 |
| Q3 2024 | 10 | -2 | 10.58M | $380.14M | +1 | −3 |
| Q2 2024 | 12 | — | 13.13M | $463.42M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 3 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 4 | Fidelity (FMR) ✦ | 5.40M | +2.0% | $68.33M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 5 | State Street Global Advisors ✦ (pasivo) | 5.27M | +57.0% | $66.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 3.55M | +11.4% | $44.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 3.41M | +261.6% | $43.18M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 3.01M | +572.9% | $38.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasivo) | 2.87M | +27.2% | $36.28M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 1.90M | — | $24.04M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Point72 Asset Management ✦ | 1.72M | +1293.4% | $21.73M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 13 | T. Rowe Price ✦ | 1.40M | -41.4% | $17.69M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Millennium Management ✦ | 413.94K | +190.0% | $5.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 345.50K | Nuevo | $4.37M | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 17 | Wellington Management ✦ | 41.91K | +23.2% | $530,224 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 18 | D. E. Shaw & Co. ✦ | 41.59K | -91.8% | $526,076 | 0.0% | ▼ Trim | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Renaissance Technologies | $4.37M | 0.0% |
Posición cerrada
| Norges Bank | $469,517 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 226 tenedores, 184.59M acciones, $2.74B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Director · 2.50K acc. @ 16.00 · $40,000
Ventas en mercado abierto (S)
Officer, Director · 5.66K acc. · $106,823
Officer · 1.29K acc. · $24,355
Officer · 185 acc. · $3,493
Officer · 3.75K acc. · $91,191
Officer · 900 acc. · $21,915
Director · 478.38K acc. · $11.96M
Director · 1.36M acc. · $33.99M
Director · 322.46K acc. · $8.06M
Officer · 1.56K acc. · $40,892
Director · 268.35K acc. · $7.03M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología